Most Popular

M & A Deals | M & A League Table | Real Assets | Sector Events |  Private Capital Conference

Switzerland: Samsung Biologics to acquire PolyPeptide for US$1.8bn

M&A Nick Herbert -
Listed South Korean CDMO, Samsung Biologics, is acquiring all shares in SIX-listed PolyPeptide, a specialised CDMO for peptide-based active pharmaceutical ingredients, for CHF44.31 per share. The offer values PolyPeptide's equity at approximately CHF1.46bn (US$1.8bn). “This acquisition reinforces our long-term growth strategy by not only broadening our service portfolio with modality...

Germany: Ardian acquires majority stake in German digital healthcare recruitment platform, Pflegia

Buy Out Nick Herbert -
Ardian, a France-based global private investment firm, has acquired a majority stake in Pflegia, digital recruitment platform for healthcare professionals in Germany. Founded in 2019, Pflegia addresses the structural healthcare staffing shortage through an AI-powered reverse-recruiting platform - leveraging the largest healthcare candidate database in Germany - enabling healthcare professionals to find their ideal positions faster and care providers to fill critical roles more efficiently. In 2024, the company extended its reach across the German healthcare ecosystem with the launch of Praxia, a dedicated platform targeting medical and dental practice staff.  Ardian's...